Turenne Capital

Created in 1999, Turenne Capital is an independent managing Company authorised by the AMF (Authorisation no. GP99-38 of 6 December 1999). Turenne Capital is specialised in private equity funding of SMEs (Small and Medium Size Enterprises) and ISEs (Intermediate Size Enterprises) to support their expansion projects. Groupe Turenne Capital has over EUR 650 million in assets under management/advisory and provides support to over 200 portfolio companies in their growth. It has 43 employees, including 30 investors, located in Paris, Lille (home to Nord Capital, its joint subsidiary with Crédit Agricole Nord de France), Lyon and Marseilles. Turenne Capital has built up a proven track record in the following key investment fields: healthcare, hotels, innovative industry, ecotechnology, specialised retail, services and IT services. Turenne Capital supports and runs the Fondation pour l'Innovation Thérapeutique Béatrice Denys (Béatrice Denys foundation for therapeutic innovation) which rewards the most successful projects within French academic research, under the aegis of the Fondation pour la Recherche Médicale.www.turennecapital.com/en